These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [New elements in the diagnosis and the treatment of primary AL amyloid polyneuropathy and neuropathy due to POEMS syndrome]. Adams D; Lozeron P; Theaudin M; Ribrag V; Bourhis JH; Lacroix C Rev Neurol (Paris); 2011 Jan; 167(1):57-63. PubMed ID: 21190703 [TBL] [Abstract][Full Text] [Related]
10. Prognosis of patients with primary systemic amyloidosis who present with dominant neuropathy. Rajkumar SV; Gertz MA; Kyle RA Am J Med; 1998 Mar; 104(3):232-7. PubMed ID: 9552085 [TBL] [Abstract][Full Text] [Related]
11. [Polyneuropathy associated with monoclonal gammopathy of undetermined significance]. Moth Henriksen M; Kolmos EB; Abildgaard N; Schrøder HD; Sindrup S Ugeskr Laeger; 2012 Oct; 174(43):2630-4. PubMed ID: 23095652 [TBL] [Abstract][Full Text] [Related]
12. Polyneuropathy with monoclonal gammopathy: studies of 11 patients. Dalakas MC; Engel WK Ann Neurol; 1981 Jul; 10(1):45-52. PubMed ID: 6267981 [TBL] [Abstract][Full Text] [Related]
13. [Management of immune suppression in systemic diseases affecting the kidney]. Ballarín J; Díaz M Nefrologia; 2008; 28 Suppl 5():91-6. PubMed ID: 18847427 [TBL] [Abstract][Full Text] [Related]
14. Polyneuropathy associated with IgA monoclonal gammopathy of undetermined significance. Simmons Z; Bromberg MB; Feldman EL; Blaivas M Muscle Nerve; 1993 Jan; 16(1):77-83. PubMed ID: 8380902 [TBL] [Abstract][Full Text] [Related]
15. Combined use of bortezomib, cyclophosphamide, and dexamethasone induces favorable hematological and organ responses in Japanese patients with amyloid light-chain amyloidosis: a single-institution retrospective study. Kikukawa Y; Yuki H; Hirata S; Ide K; Nakata H; Miyakawa T; Matsuno N; Nosaka K; Yonemura Y; Kawaguchi T; Hata H; Mitsuya H; Okuno Y Int J Hematol; 2015 Feb; 101(2):133-9. PubMed ID: 25430082 [TBL] [Abstract][Full Text] [Related]
16. Hereditary amyloid polyneuropathy-related destructive arthropathy in a hip joint. Sato S; Seki H; Ikeda SI Amyloid; 2017 Mar; 24(1):64-65. PubMed ID: 28393569 [No Abstract] [Full Text] [Related]
17. Scleroderma-like manifestation in a patient with primary systemic amyloidosis: response to high-dose intravenous immunoglobulin and plasma exchange. Cho SB; Park JS; Kim HO; Chung KY Yonsei Med J; 2006 Oct; 47(5):737-40. PubMed ID: 17066519 [TBL] [Abstract][Full Text] [Related]
19. Long standing polyneuropathy as a form of presentation of primary systemic amyloidosis. Jiménez Caballero PE Neurologia; 2012 Sep; 27(7):447-8. PubMed ID: 22217524 [No Abstract] [Full Text] [Related]
20. Primary systemic amyloidosis. Early diagnosis and therapy can improve survival rates and quality of life. Roy A; Roy V Postgrad Med; 2006; 119(1):93-9. PubMed ID: 16913652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]